You may want to parsley and dill up your food as according to a new study, they can help fight cancer.
Scientists from Moscow Institute of Physics and Technology (MIPT), the N. D. Zelinsky Institute of Organic Chemistry (RAS), the Institute of Developmental Biology (RAS) and the Institute of Cell Biophysics (RAS) proposed an efficient approach to a novel agents with anticancer activity. A synthesis of these compounds is based on compounds extracted from parsley and dill seeds.
Researcher Alexander Kiselev said that they developed a simple method of producing glaziovianin A and its structural analogs, which inhibit the growth of human tumor cells, using feasible building blocks from nature and added that evaluation of these novel agents in vivo using validated sea urchin embryo assays yielded several promising candidates selectively affecting tubulin dynamics.
The new method is cheaper than the existing ones because it involves cheap widespread materials and also reduces the number of steps in its synthesis and the list of catalysts involved.
In addition, the team synthesized a number of structural analogs of glaziovianin A in order to find new antimitotics.
The use of sea urchin embryos was another innovation offered by the team of scientists. The cells of these sea creature embryos divide rapidly in the early stages of development, simulating the way a tumor grows. When the antimitotics were added to the sea urchins' substratum, they started to rotate, making it easy for the researchers to evaluate the effect of new drugs and their side effects.
The results have been published in the Journal of Natural Products.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
